These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23206699)

  • 1. Spinocerebellar ataxia type 35 (SCA35)-associated transglutaminase 6 mutants sensitize cells to apoptosis.
    Guan WJ; Wang JL; Liu YT; Ma YT; Zhou Y; Jiang H; Shen L; Guo JF; Xia K; Li JD; Tang BS
    Biochem Biophys Res Commun; 2013 Jan; 430(2):780-6. PubMed ID: 23206699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in TGM6 induce the unfolded protein response in SCA35.
    Tripathy D; Vignoli B; Ramesh N; Polanco MJ; Coutelier M; Stephen CD; Canossa M; Monin ML; Aeschlimann P; Turberville S; Aeschlimann D; Schmahmann JD; Hadjivassiliou M; Durr A; Pandey UB; Pennuto M; Basso M
    Hum Mol Genet; 2017 Oct; 26(19):3749-3762. PubMed ID: 28934387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hispanic Spinocerebellar Ataxia Type 35 (SCA35) with a Novel Frameshift Mutation.
    Lin CC; Gan SR; Gupta D; Alaedini A; Green PH; Kuo SH
    Cerebellum; 2019 Apr; 18(2):291-294. PubMed ID: 30229425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case report of late-onset cerebellar ataxia associated with a rare p.R342W TGM6 (SCA35) mutation.
    Manini A; Bocci T; Migazzi A; Monfrini E; Ronchi D; Franco G; De Rosa A; Sartucci F; Priori A; Corti S; Comi GP; Bresolin N; Basso M; Di Fonzo A
    BMC Neurol; 2020 Nov; 20(1):408. PubMed ID: 33160304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing.
    Wang JL; Yang X; Xia K; Hu ZM; Weng L; Jin X; Jiang H; Zhang P; Shen L; Guo JF; Li N; Li YR; Lei LF; Zhou J; Du J; Zhou YF; Pan Q; Wang J; Wang J; Li RQ; Tang BS
    Brain; 2010 Dec; 133(Pt 12):3510-8. PubMed ID: 21106500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinocerebellar ataxia 35: novel mutations in TGM6 with clinical and genetic characterization.
    Guo YC; Lin JJ; Liao YC; Tsai PC; Lee YC; Soong BW
    Neurology; 2014 Oct; 83(17):1554-61. PubMed ID: 25253745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGM6 might not be a specific causative gene for spinocerebellar ataxia resulting from genetic analysis and functional study.
    Cheng HL; Dong HL; Liu DS; Ni W; Ma Y; Yang L; Du YC; Chen DF; Dong Y; Wu ZY
    Gene; 2021 May; 779():145495. PubMed ID: 33588035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of transglutaminase exacerbates polyglutamine-induced neurotoxicity by increasing the aggregation of mutant ataxin-3 in an SCA3 Drosophila model.
    Lin Y; He H; Luo Y; Zhu T; Duan R
    Neurotox Res; 2015 Apr; 27(3):259-67. PubMed ID: 25501875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A significant inflation in TGM6 genetic risk casts doubt in its causation in spinocerebellar ataxia type 35.
    Fung JLF; Tsang MHY; Leung GKC; Yeung KS; Mak CCY; Fung CW; Chan SHS; Yu MHC; Chung BHY
    Parkinsonism Relat Disord; 2019 Jun; 63():42-45. PubMed ID: 30670339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 6 interacts with polyQ proteins and promotes the formation of polyQ aggregates.
    Guan WJ; Xia KD; Ma YT; Liu YT; Shi YT; Jiang H; Shen L; Xia K; Li JD; Tang BS; Wang JL
    Biochem Biophys Res Commun; 2013 Jul; 437(1):94-100. PubMed ID: 23800413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology.
    Marsili L; Sharma J; Espay AJ; Migazzi A; Abdelghany E; Hill EJ; Duque KR; Hagen MC; Stephen CD; Kovacs GG; Lang AE; Hadjivassiliou M; Basso M; Kauffman MA; Sturchio A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole exome sequencing identifies a novel mutation in the transglutaminase 6 gene for spinocerebellar ataxia in a Chinese family.
    Li M; Pang SY; Song Y; Kung MH; Ho SL; Sham PC
    Clin Genet; 2013 Mar; 83(3):269-73. PubMed ID: 22554020
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Chen K; Lu Y; Peng F; Yu HL; Wu JY; Tan Y; Zhao YX
    J Integr Neurosci; 2020 Mar; 19(1):51-64. PubMed ID: 32259886
    [No Abstract]   [Full Text] [Related]  

  • 14. Transglutaminase 6: a protein associated with central nervous system development and motor function.
    Thomas H; Beck K; Adamczyk M; Aeschlimann P; Langley M; Oita RC; Thiebach L; Hils M; Aeschlimann D
    Amino Acids; 2013 Jan; 44(1):161-77. PubMed ID: 21984379
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Chen Y; Wu D; Luo B; Zhao G; Wang K
    Neurol Genet; 2020 Jun; 6(3):e424. PubMed ID: 32426513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of transglutaminase 6 in the central nervous system of adult mice.
    Liu YT; Tang BS; Lan W; Song NN; Huang Y; Zhang L; Guan WJ; Shi YT; Shen L; Jiang H; Guo JF; Xia K; Ding YQ; Wang JL
    Anat Rec (Hoboken); 2013 Oct; 296(10):1576-87. PubMed ID: 23836538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGM6 gene mutations in undiagnosed cerebellar ataxia patients.
    Yang ZH; Shi MM; Liu YT; Wang YL; Luo HY; Wang ZL; Shi CH; Xu YM
    Parkinsonism Relat Disord; 2018 Jan; 46():84-86. PubMed ID: 28927799
    [No Abstract]   [Full Text] [Related]  

  • 18. Most mutations that cause spinocerebellar ataxia autosomal recessive type 16 (SCAR16) destabilize the protein quality-control E3 ligase CHIP.
    Kanack AJ; Newsom OJ; Scaglione KM
    J Biol Chem; 2018 Feb; 293(8):2735-2743. PubMed ID: 29317501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue transglutaminase differentially modulates apoptosis in a stimuli-dependent manner.
    Tucholski J; Johnson GV
    J Neurochem; 2002 May; 81(4):780-91. PubMed ID: 12065637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a highly reactive substrate peptide for transglutaminase 6 and its use in detecting transglutaminase activity in the skin epidermis.
    Fukui M; Kuramoto K; Yamasaki R; Shimizu Y; Itoh M; Kawamoto T; Hitomi K
    FEBS J; 2013 Mar; 280(6):1420-9. PubMed ID: 23331848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.